India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.
'We need to prove to the world that quality vaccines and R&D are possible in India.'
The parents denied allegations that their son had joined IS and said the money was for their son to buy a new pair of glasses.
The Rhodes scholarship is an annual scholarship awarded to people who perform exceptionally well in academics, sports and community service. Winners of the scholarship are given the opportunity to study at the prestigious Oxford University. We profile some of the notable personalities who have won the scholarship.
A poet, a novelist, a columnist and writer of short stories and travelogues, Dev Sen was also known for her research on the Ramayana.
Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.
Billionaire Mukesh Ambani's Reliance Industries Ltd on Friday announced the buyout of British battery maker Faradion Ltd for an enterprise value of 100 million, as the oil-to-retail conglomerate continued with the acquisition of end-to-end technology for its multi-billion-dollar clean energy portfolio. Reliance New Energy Solar Ltd (RNESL), a unit of the nation's most valuable company, signed definitive agreements to acquire 100 per cent shareholding in Faradion for an enterprise value of 100 million and will invest an additional 25 million as growth capital to accelerate the commercial roll-out, the company said in a statement. Based out of Sheffield and Oxford in the UK and with its patented sodium-ion battery technology, Faradion is one of the leading global battery technology companies.
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:
A summary of Saturday's matches in the FA Cup.
India has received over USD 20 billion in FDI amid the coronavirus pandemic, Foreign Secretary Harsh Vardhan Shringla said on Tuesday, showcasing the country as one of the most attractive destinations for investment globally.
Khan, who is believed to have the backing of the powerful military, has vowed to make a 'Naya Pakistan' which would be an Islamic welfare state.
The Union health ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covishield and Covaxin vaccines started in the country and of these 700 cases were reported to be serious.
'People may think that because my father was in the film world and politics, things are easy for me.' 'It is not easy at all.'
'Great social change brings great linguistic change, and that has never been truer than in this current global crisis.'
There has been a major shift in the global balance of economic power, creating a new global hierarchy dominated by the East, says Chris Patten, chancellor of Oxford University. Naomi Canton reports.
'The big power struggle in faraway Europe erupted at a most critical juncture when India has been increasingly sceptical about American policies and statesmanship,' argues Ambassador M K Bhadrakumar.
Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.
An important focus of the dry run will be on management of any possible adverse events following immunisation.
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.
A technical advisory group of the UN health agency which met on Tuesday has sought "additional clarifications" from Bharat Biotech for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.
By January-February, it's expected to have at least 100 million doses for the Indian government, reports Sohini Das.
Selected students from India will win a fully funded scholarship to pursue a master's programme at the Oxford University in the UK in 2014.
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
'She seems to have disappeared off the face of the planet after telling different people different things.'
Ahmedabad was the first stop in the PM's three city tour today, to personally review the vaccine development and manufacturing process in the country.
Para-athlete and current para-badminton world champion Manasi Joshi, climate activist Ridhima Pandey and Isaivani for breaking male domination in the field of Tamil Nadu's Gaana singing also made the list.
The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.
From the middle of next week, shops, personal care, gyms and churches can reopen as part of a bolstered three-tiered system. As part of the restrictions, people will be expected to continue to work from home if they live in a Tier 1 region; in Tier 2, alcohol can only be served with a meal; and in Tier 3, all forms of hospitality except takeaways will have to close.
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.
Some important simple truths about the issue may be more helpful than high sounding debates, asserts Mohammad Sajjad.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
Amidst acute poverty across South Asia, the five states of Delhi, Kerala, Goa, Punjab and Himachal Pradesh have the least number of poor people in India, according to a new measure of global poverty developed at the University of Oxford for the UNDP.
In a tweet, Prime Minister Narendra Modi said India is deeply honoured to be a 'long-trusted' partner in meeting the healthcare needs of the global community and that supplies of the vaccines to several countries will commence on Wednesday, and more will follow in the days ahead.
Out of the 447 adverse events following immunisation, only 3 required hospitalisation.
Senior Congress leader Manish Tewari and Union Health Minister Harsh Vardhan sparred on Twitter on Saturday with the Opposition leader raising questions over the emergency use approval given to the indigenously developed vaccine Covaxin and the Bharatiya Janata Party leader hitting back alleging that Tewari was only passionate about spreading rumours.
First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India.
